GLYSTALI Trademark

Trademark Overview


On Friday, June 10, 2022, a trademark application was filed for GLYSTALI with the United States Patent and Trademark Office. The USPTO has given the GLYSTALI trademark a serial number of 97453092. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, June 24, 2024. This trademark is owned by Zydus Pharmaceuticals (USA) Inc.. The GLYSTALI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations fo...
glystali

General Information


Serial Number97453092
Word MarkGLYSTALI
Filing DateFriday, June 10, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, June 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Goods and ServicesAnti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZydus Pharmaceuticals (USA) Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534

Party NameZydus Pharmaceuticals (USA) Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534

Trademark Events


Event DateEvent Description
Tuesday, June 14, 2022NEW APPLICATION ENTERED
Thursday, June 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU EXTENSION 2 FILED
Monday, June 24, 2024SOU EXTENSION 2 GRANTED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 1 FILED
Tuesday, December 19, 2023SOU EXTENSION 1 GRANTED